In hepatocellular carcinoma, there is a significant correlation between decreased PRMT6 expression and short overall survival, whereas PRMT6 overexpression is associated with tumorigenicity and invasiveness in gastric cancer and lung cancer [17, 18]. This evidence concerns the gene PRMT6 and lung cancer.